Holdings Channel
Play Video: The Importance of Insider Buying


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Quotes delayed 20 minutes

Email EnvelopeFree HGEN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Other companies seeing insider buying close in time to when the HGEN Insider Buying occurred are:

SGMS Insider Buying
TRIP Insider Buying
TSP Insider Buying
NJMC Insider Buying
CLOV Insider Buying
OTMO Insider Buying
WLK Insider Buying
LSYN Insider Buying
PLXP Insider Buying
DKNG Insider Buying

HGEN insider buying image
The table below summarizes the most recent HGEN insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why HGEN insider buys are important for investors to follow.
DateInsiderPriceAmount
3-11-2022
Insider Buy
Dale Chappell
Chief Scientific Officer
$3.00
CAGR »
$3,000,000.00
1,000,000 shares
3-9-2022
Insider Buy
Adrian Kilcoyne
Chief Medical Officer
$2.63
CAGR »
$31,610.00
12,000 shares
3-2-2022
Insider Buy
Edward P. Jordan
Chief Commercial Officer
$2.32
CAGR »
$29,000.00
12,500 shares
3-2-2022
Insider Buy
Cameron Durrant
Chief Executive Officer
$2.34
CAGR »
$93,600.00
40,000 shares

Also See: Institutional Holders of HGEN
Also See: SEC filings

HGEN Performance Since Insider Purchase
Below we present the annualized performance delivered by HGEN stock since 3-11-2022 (the date of the most recent insider purchase). The performance of the investment from the time HGEN insider buying occurred is the ultimate test of whether insiders were right about HGEN being a good buy.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 03/14/2022
End date: 10/20/2023
Start price/share: $2.61
End price/share: $0.01
Dividends collected/share: $0.00
Total return: -99.62%
Average Annual Total Return: -96.89%
Starting investment: $10,000.00
Ending investment: $38.40
Years: 1.60

HGEN Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent HGEN insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding HGEN

HGEN Insider Buying | www.HoldingsChannel.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.